Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Involvement of the Central Nervous System in Patients With Covid-19 Publisher Pubmed



Saleki K1 ; Banazadeh M1 ; Saghazadeh A1, 2 ; Rezaei N2, 3, 4
Authors

Source: Reviews in the Neurosciences Published:2020


Abstract

Coronaviruses disease (COVID-19) has caused major outbreaks. A novel variant, SARS-CoV-2, is responsible for COVID-19 pandemic. Clinical presentations and pathological mechanisms of COVID-19 are broad. The respiratory aspect of the disease has been extensively researched. Emerging studies point out the possibility of the central nervous system (CNS) involvement by COVID-19. Here, we discuss the current evidence for CNS involvement in COVID-19 and highlight that the high pathogenicity of SARS-CoV-2 might be due to its neuroinvasive potential. © 2020 Walter de Gruyter GmbH, Berlin/Boston 2020.
Related Docs
View other Related Docs
1. Covid-19 Virus May Have Neuroinvasive Potential and Cause Neurological Complications: A Perspective Review, Journal of NeuroVirology (2020)
2. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
3. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Farshid Noorbakhsh (1)
Other Related Docs
4. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
5. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
6. Immune Mechanisms in the Pathogenesis of Coronavirus Disease 2019, Journal of Cellular and Molecular Anesthesia (2022)
7. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
8. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
9. Potential Role of Interferons in Treating Covid-19 Patients, International Immunopharmacology (2021)
10. Immune Responses and Pathogenesis of Sars-Cov-2 During an Outbreak in Iran: Comparison With Sars and Mers, Reviews in Medical Virology (2020)
11. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)
12. Towards Treatment Planning of Covid-19: Rationale and Hypothesis for the Use of Multiple Immunosuppressive Agents: Anti-Antibodies, Immunoglobulins, and Corticosteroids, International Immunopharmacology (2020)
13. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
14. The Outlook for Diagnostic Purposes of the 2019-Novel Coronavirus Disease, Journal of Cellular Physiology (2020)
15. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
16. Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine, International Immunopharmacology (2020)
17. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)
18. Cutaneous Manifestation of Covid-19: What Have We Learned an Year Into the Pandemic?; [Manifestaciones Cutaneas De La Covid-19: ¿Que Hemos Aprendido Tras Un Ano De Pandemia?], Actas Dermo-Sifiliograficas (2021)
19. Cutaneous Manifestation of Covid-19: What Have We Learned an Year Into the Pandemic?; [[Articulo Traducido] Manifestaciones Cutaneas De La Covid-19: ¿Que Hemos Aprendido Tras Un Ano De Pandemia?], Actas Dermo-Sifiliograficas (2022)
20. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)